Pharmacokinetics and pharmacodynamics of continuous-infusion meropenem in pediatric hematopoietic stem cell transplant patients

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 9, 2015, Pages 5535-5541

  Cojutti, Piergiorgio ^a,b   Maximova, Natalia ^c   Pea, Federico ^a,b  

^a SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; COLISTIN; CREATININE; LINEZOLID; MEROPENEM; TEICOPLANIN; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT; THIENAMYCIN DERIVATIVE;

ABDOMINAL INFECTION; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; APLASTIC ANEMIA; ARTICLE; BACTERIAL PNEUMONIA; BLOODSTREAM INFECTION; CHEDIAK HIGASHI SYNDROME; CHILD; CLINICAL ARTICLE; CONCENTRATION AT STEADY-STATE; CONTINUOUS INFUSION; CREATININE CLEARANCE; DRUG CLEARANCE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MONITORING; ESCHERICHIA COLI INFECTION; EWING SARCOMA; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEBRILE NEUTROPENIA; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; JUVENILE MYELOMONOCYTIC LEUKEMIA; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LOADING DRUG DOSE; MALE; MINIMUM INHIBITORY CONCENTRATION; MONTE CARLO METHOD; NEUROBLASTOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RECOMMENDED DRUG DOSE; RETROSPECTIVE STUDY; SCHOOL CHILD; SICKLE CELL ANEMIA; URINARY TRACT INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MICROBIAL SENSITIVITY TEST;

ANTI-BACTERIAL AGENTS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFUSIONS, INTRAVENOUS; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES; THIENAMYCINS;

EID: 84940917393     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00787-15     Document Type: Article

References (41)

1. Quarello P, Saracco P, Giacchino M., Caselli D, Caviglia I, Longoni D., Varotto S, Rana I, Amendola A., Misuraca A, Licciardello M, Paolucci P., Ladogana S, Rivetti E, Dufour C., Castagnola E. 2012. Epidemiology of infections in children with acquired aplastic anaemia: a retrospective multicenter study in Italy. Eur J Haematol 88:526-534. http://dx.doi.org/10.1111/j.1600-0609.2012.01770.x.
2. Caselli D, Cesaro S, Ziino O., Zanazzo G, Manicone R, Livadiotti S., Cellini M, Frenos S, Milano G.M., Cappelli B., Licciardello M, Beretta C, Arico M., Castagnola E, Infection Study Group of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). 2010. Multidrug resistant Pseudomonas aeruginosa infection in children undergoing chemotherapy and hematopoietic stem cell transplantation. Haematologica 95:1612-1615. http://dx.doi.org/10.3324/haematol.2009.020867.
3. Haeusler GM, Mechinaud F, Daley A.J., Starr M., Shann F, Connell TG, Bryant P.A., Donath S., Curtis N. 2013. Antibiotic-resistant Gramnegative bacteremia in pediatric oncology patients-risk factors and outcomes. Pediatr Infect Dis J 32:723-726. http://dx.doi.org/10.1097/INF.0b013e31828aebc8.
4. Folgori L, Livadiotti S, Carletti M., Bielicki J, Pontrelli G, Ciofi Degli Atti ML, Bertaina C, Lucignano B, Ranno S, Carretto E, Muraca M, Sharland M, Bernaschi P. 2014. Epidemiology and clinical outcomes of multidrug-resistant, Gram-negative bloodstream infections in a European tertiary pediatric hospital during a 12-month period. Pediatr Infect Dis J 33:929-932. http://dx.doi.org/10.1097/INF.0000000000000339.
5. Park SH, Milstone AM, Diener-West M, Nussenblatt V., Cosgrove SE, Tamma PD. 2014. Short versus prolonged courses of antibiotic therapy for children with uncomplicated Gram-negative bacteraemia. J Antimicrob Chemother 69:779-785. http://dx.doi.org/10.1093/jac/dkt424.
6. Raymond J, Nordmann P, Doit C., Vu Thien H, Guibert M, Ferroni A., Aujard Y. 2007. Multidrug-resistant bacteria in hospitalized children: a 5-year multicenter study. Pediatrics 119:e798-e803. http://dx.doi.org/10.1542/peds.2006-1384.
7. Lukac PJ, Bonomo RA, Logan LK 2015. Extended-spectrum β-lactamase-producing Enterobacteriaceae in children: old foe, emerging threat. Clin Infect Dis 60:1389-1397. http://dx.doi.org/10.1093/cid/civ020.
8. Logan LK. 2012. Carbapenem-resistant Enterobacteriaceae: an emerging problem in children. Clin Infect Dis 55:852-859. http://dx.doi.org/10.1093/cid/cis543.
9. Ciofi Degli Atti M, Bernaschi P, Carletti M, Luzzi I, Garcia-Fernandez A, Bertaina A, Sisto A, Locatelli F, Raponi M. 2014. An outbreak of extremely drug-resistant Pseudomonas aeruginosa in a tertiary care pediatric hospital in Italy. BMC Infect Dis 14:494. http://dx.doi.org/10.1186/1471-2334-14-494.
10. Fleischhack G, Hartmann C, Simon A., Wulff B, Havers W, Marklein G., Hasan C, Bode U. 2001. Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer. J Antimicrob Chemother 47:841-853. http://dx.doi.org/10.1093/jac/47.6.841.
11. Erbey F, Bayram I, Yilmaz S., Tanyeli A. 2010. Meropenem monotherapy as an empirical treatment of febrile neutropenia in childhood cancer patients. Asian Pac J Cancer Prev 11:123-126.
12. Hsu AJ, Tamma PD 2014. Treatment of multidrug-resistant Gramnegative infections in children. Clin Infect Dis 58:1439-1448. http://dx.doi.org/10.1093/cid/ciu069.
13. Castagnola E, Faraci M. 2009. Management of bacteremia in patients undergoing hematopoietic stem cell transplantation. Expert Rev Anti Infect Ther 7:607-621. http://dx.doi.org/10.1586/eri.09.35.
14. Ellis JM, Kuti JL, Nicolau DP 2005. Use of Monte Carlo simulation to assess the pharmacodynamics of beta-lactams against Pseudomonas aeruginosa infections in children: a report from the OPTAMA program. Clin Ther 27:1820-1830. http://dx.doi.org/10.1016/j.clinthera.2005.11.007.
15. Cies JJ, Shankar V, Schlichting C., Kuti JL. 2014. Population pharmacokinetics of piperacillin/tazobactam in critically ill young children. Pediatr Infect Dis J 33:168-173. http://dx.doi.org/10.1097/INF.0b013e3182a743c7.
16. Cies JJ, Moore WS, Jr, Dickerman MJ, Small C, Carella D, Chopra A, Parker J. 2014. Pharmacokinetics of continuous-infusion meropenem in a pediatric patient receiving extracorporeal life support. Pharmacotherapy 34:e175-e179. http://dx.doi.org/10.1002/phar.1476.
17. Courter JD, Kuti JL, Girotto J.E., Nicolau DP. 2009. Optimizing bactericidal exposure for beta-lactams using prolonged and continuous infusions in the pediatric population. Pediatr Blood Cancer 53:379-385. http://dx.doi.org/10.1002/pbc.22051.
18. Ohata Y, Tomita Y, Nakayama M., Kozuki T, Sunakawa K, Tanigawara Y. 2011. Optimal dosage regimen of meropenem for pediatric patients based on pharmacokinetic/pharmacodynamic considerations. Drug Metab Pharmacokinet 26:523-531. http://dx.doi.org/10.2133/dmpk.DMPK-11-RG-027.
19. Walker MC, Lam WM, Manasco KB 2012. Continuous and extended infusions of β-lactam antibiotics in the pediatric population. Ann Pharmacother 46:1537-1546. http://dx.doi.org/10.1345/aph.1R216.
20. Jaruratanasirikul S, Limapichat T, Jullangkoon M., Aeinlang N, Ingviya N, Wongpoowarak W. 2011. Pharmacodynamics of meropenem in critically ill patients with febrile neutropenia and bacteraemia. Int J Antimicrob Agents 38:231-236. http://dx.doi.org/10.1016/j.ijantimicag.2011.04.019.
21. Ariano RE, Nyhlen A, Donnelly J.P., Sitar DS, Harding GK, Zelenitsky SA. 2005. Pharmacokinetics and pharmacodynamics of meropenem in febrile neutropenic patients with bacteremia. Ann Pharmacother 39:32-38.
22. Franceschi L, Cojutti P, Baraldo M., Pea F. 2014. Stability of generic meropenem solutions for administration by continuous infusion at normal and elevated temperatures. Ther Drug Monit 36:674-676. http://dx.doi.org/10.1097/FTD.0000000000000054.
23. Li C, Du X, Kuti J.L., Nicolau DP. 2007. Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections. Antimicrob Agents Chemother 51:1725-1730. http://dx.doi.org/10.1128/AAC.00294-06.
24. Pea F, Cojutti P, Merelli M., Crapis M, Bassetti M. 2014. Treatment of consecutive episodes of multidrug-resistant bacterial pleurisy with different aetiology in a heart transplant candidate: proof of concept of pharmacokinetic/pharmacodynamic optimisation of antimicrobial therapy at the infection site. Int J Antimicrob Agents 44:570-571. http://dx.doi.org/10.1016/j.ijantimicag.2014.09.003.
25. Pea F, Viale P, Cojutti P., Furlanut M. 2012. Dosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe Gram-negative infections: a pharmacokinetics/pharmacodynamics-based approach. Antimicrob Agents Chemother 56:6343-6348. http://dx.doi.org/10.1128/AAC.01291-12.
26. Tam VH, Nikolaou M. 2011. A novel approach to pharmacodynamic assessment of antimicrobial agents: new insights to dosing regimen design. PLoS Comput Biol 7:e1001043. http://dx.doi.org/10.1371/journal.pcbi.1001043.
27. Tam VH, Schilling AN, Neshat S, Poole K., Melnick DA, Coyle EA. 2005. Optimization of meropenem minimum concentration/MIC ratio to suppress in vitro resistance of Pseudomonas aeruginosa. Antimicrob Agents Chemother 49:4920-4927. http://dx.doi.org/10.1128/AAC.49.12.4920-4927.2005.
28. Mendez AS, Steppe M, Schapoval EE 2003. Validation of HPLC and UV spectrophotometric methods for the determination of meropenem in pharmaceutical dosage form. J Pharm Biomed Anal 33:947-954. http://dx.doi.org/10.1016/S0731-7085(03)00366-2.
29. Pea F, Cojutti P, Sbrojavacca R., Cadeo B, Cristini F, Bulfoni A., Furlanut M. 2011. TDM-guided therapy with daptomycin and meropenem in a morbidly obese, critically ill patient. Ann Pharmacother 45: e37. http://dx.doi.org/10.1345/aph.1P745.
30. Schwartz GJ, Work DF 2009. Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol 4:1832-1843. http://dx.doi.org/10.2215/CJN.01640309.
31. Parker EM, Hutchison M, Blumer JL 1995. The pharmacokinetics of meropenem in infants and children: a population analysis. J Antimicrob Chemother 36(Suppl A):63-71.
32. Du X, Li C, Kuti J.L., Nightingale CH, Nicolau DP. 2006. Population pharmacokinetics and pharmacodynamics of meropenemin pediatric patients. J Clin Pharmacol 46:69-75. http://dx.doi.org/10.1177/0091270005283283.
33. van den Anker JN, Pokorna P, Kinzig-Schippers M, Martinkova J., de Groot R, Drusano GL, Sorgel F. 2009. Meropenem pharmacokinetics in the newborn. Antimicrob Agents Chemother 53:3871-3879. http://dx.doi.org/10.1128/AAC.00351-09.
34. Hazar V, Gungor O, Guven A.G., Aydin F., Akbas H, Gungor F, Tezcan G., Akman S, Yesilipek A. 2009. Renal function after hematopoietic stem cell transplantation in children. Pediatr Blood Cancer 53:197-202. http://dx.doi.org/10.1002/pbc.22030.
35. Jacobson P, West N, Hutchinson RJ 1997. Predictive ability of creatinine clearance estimate models in pediatric bone marrow transplant patients. Bone Marrow Transplant 19:481-485. http://dx.doi.org/10.1038/sj.bmt.1700688.
36. Kletzel M, Pirich L, Haut P., Cohn RA. 2005. Comparison of Tc-99 measurement of glomerular filtration rate vs. calculated creatinine clearance to assess renal function pretransplant in pediatric patients undergoing hematopoietic stem cell transplantation. Pediatr Transplant 9:584-588. http://dx.doi.org/10.1111/j.1399-3046.2005.00340.x.
37. Schwartz GJ, Brion LP, Spitzer A. 1987. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34:571-590.
38. Qayed M, Thompson A, Applegate K., Haight A, Rogatko A, Chiang K.Y., Horan J. 2010. Is the updated Schwartz formula appropriate for assessing renal function prior to hematopoietic stem cell transplantation? Pediatr Blood Cancer 55:199-201.
39. Alford EL, Chhim RF, Crill C.M., Hastings MC, Ault BH, Shelton CM. 2014. Glomerular filtration rate equations do not accurately predict vancomycin trough concentrations in pediatric patients. Ann Pharmacother 48:691-696. http://dx.doi.org/10.1177/1060028014527908.
40. Ikawa K, Morikawa N, Ikeda K., Miki M, Kobayashi M. 2010. Population pharmacokinetics and pharmacodynamics of meropenem in Japanese pediatric patients. J Infect Chemother 16:139-143. http://dx.doi.org/10.1007/s10156-009-0025-0.
41. Zobell JT, Ferdinand C, Young DC 2014. Continuous infusion meropenem and ticarcillin-clavulanate in pediatric cystic fibrosis patients. Pediatr Pulmonol 49:302-306. http://dx.doi.org/10.1002/ppul.22820.